This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
GAPDH antibody
catalog :
VPA00187KT
quantity :
2 Westerns
price :
108 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot
product information
EntityType :
PrecisionAbâ„¢ Polyclonal
EntityCategory :
Antibodies
ProductCode :
VPA00187KT
Description :
GAPDH ANTIBODY WITH CONTROL LYSATE
Specificity :
GAPDH
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB
ApplicationTypes :
Western Blotting
CrossReactivities :
Mouse, Rat
Quantity :
2 Westerns
QuantityValue :
2
QuantityType :
Westerns
GOAccessions :
GO:0005515, GO:0016020, GO:0004365, GO:0005829, GO:0005634, GO:0006094, GO:0006096, GO:0055114, GO:0050821, GO:0035605, GO:0035606, GO:0048471, GO:0051287, GO:0051402
GOTerms :
3-phosphoglyceraldehyde dehydrogenase activity, alpha-2 macroglobulin receptor-associated protein activity, anaerobic glycolysis, apoptosis of neuronal cells, apoptosis of neurons, cell nucleus, cysteine to cysteine nitrosylation, cysteine-to-cysteine transnitrosylation, dehydrogenase, glyceraldehyde phosphate, D-glyceraldehyde-3-phosphate:NAD+ oxidoreductase (phosphorylating), Embden-Meyerhof pathway, Embden-Meyerhof-Parnas pathway, GAPDH activity, glucose biosynthesis, glucose biosynthetic process, glyceraldehyde phosphate dehydrogenase (NAD), glyceraldehyde-3-P-dehydrogenase activity, GO:0019641, GO:0019642, GO:0045308, GO:0051288, lysosomal protein stabilization, modifed Embden-Meyerhof pathway, NAD or NADH binding, NAD+ or NADH binding, NAD-dependent glyceraldehyde phosphate dehydrogenase activity, NAD-dependent glyceraldehyde-3-phosphate dehydrogenase activity, NADH-glyceraldehyde phosphate dehydrogenase activity, neuron programmed cell death by apoptosis, neuronal cell apoptosis, neuronal cell programmed cell death by apoptosis, nicotinamide adenine dinucleotide binding, oxidation reduction, oxidoreductase process, phosphoglyceraldehyde dehydrogenase activity, positive regulation of protein stability, programmed cell death of neuronal cells by apoptosis, programmed cell death of neurons by apoptosis, programmed cell death, neuronal cells, programmed cell death, neurons, protein amino acid binding, protein degradation tagging activity, protein folding chaperone, protein nitrosylase activity, protein sequestering, protein stabilization activity, protein tagging activity, protein-to-protein transnitrosylation, S-nitrosylase activity, S-transnitrosylation, triosephosphate dehydrogenase activity
UniprotAccessions :
P04406
Gene :
GAPDH
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2597
EntityFormats :
Purified
UNSPSC :
12352203
ProductForm :
Purified IgG - liquid
PriceDKK :
804
PrimarySecondary :
Primary
PriceGBP :
83
PriceEUR :
108
PriceUSD :
108 USD
PriceCHF :
126
PriceSEK :
1077
PriceNOK :
1070
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.